PubRank

Giampiero Girolomoni

Author PubWeight™ 126.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010 2.46
2 The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 2007 2.17
3 Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors. Arch Toxicol 2014 2.13
4 The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs 2014 1.99
5 CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006 1.77
6 Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009 1.72
7 Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 2003 1.69
8 Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 2008 1.67
9 Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges 2010 1.60
10 Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 2005 1.54
11 Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2002 1.44
12 Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 2003 1.43
13 Annular lichenoid dermatitis of youth. J Am Acad Dermatol 2003 1.40
14 Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 2006 1.40
15 Subcutaneous sarcoidosis: report of two cases and review of the literature. Clin Rheumatol 2011 1.29
16 Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol 2007 1.26
17 Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J 2002 1.24
18 ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 2005 1.23
19 The role of chemokines in allergic contact dermatitis. Arch Dermatol Res 2002 1.22
20 Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 2008 1.21
21 Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 2009 1.21
22 Drug-induced lupus erythematosus. Arch Dermatol Res 2008 1.16
23 Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol 2013 1.15
24 EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. J Invest Dermatol 2009 1.09
25 STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J 2010 1.09
26 Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol 2010 1.09
27 Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003 1.09
28 Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 2002 1.08
29 Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005 1.08
30 Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2008 1.06
31 Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 2005 1.03
32 The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford) 2012 1.02
33 Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol 2002 1.00
34 Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release. J Cell Physiol 2004 0.99
35 Erythema nodosum: etiological factors and relapses in a retrospective cohort study. Eur J Dermatol 2010 0.99
36 Chemokine networks in inflammatory skin diseases. Eur J Dermatol 2004 0.98
37 Canine models of atopic dermatitis: a useful tool with untapped potential. J Invest Dermatol 2009 0.98
38 Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 2012 0.97
39 The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol 2006 0.97
40 Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 2002 0.97
41 H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004 0.96
42 Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part II. Systemic diseases. J Am Acad Dermatol 2010 0.96
43 Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. J Leukoc Biol 2008 0.96
44 Mid-dermal elastolysis: a clinical, histologic, and immunohistochemical study of 11 patients. J Am Acad Dermatol 2003 0.95
45 Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system. J Immunol 2002 0.95
46 Expression and function of histamine receptors in human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002 0.95
47 Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations. Am J Clin Oncol 2016 0.93
48 Usefulness of the framingham risk score in patients with chronic psoriasis. Am J Cardiol 2010 0.93
49 Endometriosis of umbilical cicatrix: case report and review of the literature. Acta Dermatovenerol Croat 2008 0.92
50 Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes. J Invest Dermatol 2006 0.92
51 Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21. Hum Hered 2006 0.91
52 Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS One 2008 0.91
53 Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol 2002 0.91
54 Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis. Expert Opin Ther Targets 2008 0.91
55 Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat 2010 0.91
56 Drug-induced morphea: report of a case induced by balicatib and review of the literature. J Am Acad Dermatol 2008 0.91
57 Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents. J Dtsch Dermatol Ges 2012 0.89
58 Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity 2010 0.89
59 The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol 2009 0.89
60 Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo. Am J Pathol 2002 0.88
61 Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy. Dermatol Ther (Heidelb) 2014 0.88
62 Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol 2004 0.87
63 The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 2002 0.87
64 Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. Acta Derm Venereol 2014 0.87
65 Microcirculatory modifications of psoriatic lesions during topical therapy. Skin Res Technol 2009 0.87
66 Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy. Am J Clin Dermatol 2010 0.87
67 The diagnostic and therapeutic challenge of early psoriatic arthritis. Dermatology 2010 0.87
68 Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol 2011 0.86
69 Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 2010 0.86
70 Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist 2011 0.85
71 Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis. Acta Derm Venereol 2016 0.85
72 Pimecrolimus in dermatology: atopic dermatitis and beyond. Int J Clin Pract 2005 0.84
73 Biologic therapies in psoriasis: a new therapeutic approach. Autoimmun Rev 2007 0.84
74 Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis. J Invest Dermatol 2002 0.84
75 Contact allergy in chronic eczematous lip dermatitis. Eur J Dermatol 2008 0.84
76 Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder? J Invest Dermatol 2007 0.84
77 Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system. Dermatol Ther 2010 0.84
78 Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. J Interferon Cytokine Res 2003 0.83
79 Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology 2014 0.83
80 Buschke-Ollendorff syndrome. Int J Dermatol 2008 0.83
81 Psoriasis and risk of myocardial infarction. JAMA 2007 0.83
82 Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation. Clinicoecon Outcomes Res 2012 0.83
83 Folic acid in general medicine and dermatology. J Dermatolog Treat 2007 0.82
84 Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. Immunol Res 2013 0.82
85 Videocapillaroscopy in the differential diagnosis between psoriasis and seborrheic dermatitis of the scalp. Dermatology 2007 0.82
86 Targeting tumor necrosis factor-alpha in the therapy of psoriasis. Curr Drug Targets Inflamm Allergy 2004 0.82
87 Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol 2006 0.81
88 Videocapillaroscopic alterations in erythematotelangiectatic rosacea. J Am Acad Dermatol 2005 0.81
89 Efficacy of a single educative intervention in patients with chronic plaque psoriasis. Dermatology 2009 0.81
90 Psoriasis, the liver, and the gastrointestinal tract. Dermatol Ther 2010 0.81
91 Predictive model for delayed graft function based on easily available pre-renal transplant variables. Intern Emerg Med 2014 0.81
92 Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol Ther 2008 0.81
93 Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part I. Cutaneous diseases. J Am Acad Dermatol 2010 0.81
94 Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis? J Eur Acad Dermatol Venereol 2012 0.80
95 House dust mite allergen exerts no direct proinflammatory effects on human keratinocytes. J Allergy Clin Immunol 2002 0.80
96 Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor. Future Oncol 2014 0.80
97 Activation of nickel-specific CD4+ T lymphocytes in the absence of professional antigen-presenting cells. J Invest Dermatol 2002 0.80
98 Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. Dermatology 2012 0.80
99 AAITO Position paper. Chronic urticaria: diagnostic workup and treatment. Eur Ann Allergy Clin Immunol 2007 0.79
100 Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal transplant patient. J Clin Microbiol 2003 0.79
101 The role of interleukin-17A in psoriatic disease. BioDrugs 2014 0.79
102 Severe impairment of quality of life in Hailey-Hailey disease. Acta Derm Venereol 2005 0.79
103 Purely follicular mycosis fungoides without mucinosis: report of two cases with review of the literature. J Am Acad Dermatol 2003 0.79
104 Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol 2006 0.79
105 Balneotherapy for chronic plaque psoriasis at Comano spa in Trentino, Italy. Dermatol Ther 2008 0.78
106 Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy. J Dermatolog Treat 2011 0.78
107 Prurigo nodularis: an update on etiopathogenesis and therapy. J Dermatolog Treat 2013 0.78
108 Nodular perianal herpes simplex with prominent plasma cell infiltration. Sex Transm Dis 2003 0.78
109 Fibulin Protein Expression in Mid-dermal Elastolysis and Anetoderma: A Study of 23 Cases. Acta Derm Venereol 2016 0.78
110 BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression. Int Immunopharmacol 2006 0.77
111 Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. Eur J Cancer Prev 2012 0.77
112 Perception of disease and doctor-patient relationship experienced by patients with psoriasis: a questionnaire-based study. Am J Clin Dermatol 2009 0.77
113 Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia. Oncologist 2009 0.77
114 Suppressor of cytokine signaling-1 inhibits interferon-gamma-induced activation of human keratinocytes. Ann N Y Acad Sci 2002 0.77
115 Comparative genomic hybridization identifies 17q11.2 approximately q12 duplication as an early event in cutaneous T-cell lymphomas. Cancer Genet Cytogenet 2008 0.77
116 Acneiform eruption induced by cetuximab. Acta Dermatovenerol Croat 2007 0.77
117 Allergic contact dermatitis in children with and without atopic dermatitis. Dermatitis 2012 0.76
118 Erosive pustular dermatosis of the leg: long-term control with topical tacrolimus. Australas J Dermatol 2011 0.76
119 Patients with psoriasis have a higher prevalence of parental cardiovascular disease. Dermatology 2011 0.76
120 Idiopathic CD4+ T lymphocytopenia associated with disseminated flat warts and alopecia areata. J Dermatol 2002 0.76
121 Erythrocytes deliver Tat to interferon-gamma-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro. J Leukoc Biol 2002 0.76
122 Subacute cutaneous lupus erythematosus induced by nifedipine. J Cutan Med Surg 2005 0.76
123 Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis. J Interferon Cytokine Res 2006 0.76
124 Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence. J Dermatolog Treat 2012 0.76
125 Inosine stimulates chemotaxis, Ca2+-transients and actin polymerization in immature human dendritic cells via a pertussis toxin-sensitive mechanism independent of adenosine receptors. J Cell Physiol 2004 0.76
126 Epidermal growth factor receptor ligands and tumor necrosis factor-alpha coregulate chemokine expression in human keratinocytes. Ann N Y Acad Sci 2002 0.76
127 Cutaneous manifestations of Churg-Strauss syndrome: report of two cases and review of the literature. Clin Rheumatol 2010 0.76
128 Replica to K. Takeda et al. Commentary to Pastore et al. (2014): epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors. Arch Toxicol 2014 0.75
129 Treatment of psoriasis with efalizumab in patients with hepatitis C viral infection: report of five cases. Dermatology 2009 0.75
130 Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs". BioDrugs 2015 0.75
131 Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: a multicenter cohort study. Clin Transplant 2009 0.75
132 Etanercept provides a more physiological approach in the treatment of psoriasis. Dermatol Ther 2008 0.75
133 Identification of the keratin K9 R162W mutation in patients of Italian origin with epidermolytic palmoplantar keratoderma. Eur J Dermatol 2004 0.75
134 Autoimmune progesterone dermatitis. Gynecol Endocrinol 2006 0.75
135 Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia. Eur J Dermatol 2002 0.75
136 Immunoregulation of hapten and drug induced immune reactions. Curr Opin Allergy Clin Immunol 2003 0.75
137 Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature. Dermatology 2015 0.75
138 Skin disease in the Medici family and the illness of Contessina de' Bardi de' Medici: a dermatological puzzle. Int J Dermatol 2014 0.75
139 Analysis of the 3'UTR of the prostaglandin synthetase-2 (PTGS-2/COX-2) gene in non-melanoma skin cancer after organ transplantation. Exp Dermatol 2011 0.75
140 Papular neutrophilic dermatosis and erythema elevatum diutinum following erythropoietin therapy in a patient with myelodysplastic syndrome. Acta Derm Venereol 2003 0.75
141 Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003 0.75
142 Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis. Acta Derm Venereol 2017 0.75
143 Cutaneous necrosis complicating the injection of pegylated interferon alpha-2b in a patient with chronic hepatitis C. Acta Dermatovenerol Croat 2008 0.75
144 Eruptive disseminated porokeratosis associated with internal malignancies: a case report. Cutis 2010 0.75
145 Coma blisters in children: case report and review of the literature. J Child Neurol 2012 0.75
146 The facial grid analysis for filler injection: a cohort study of 300 patients. G Ital Dermatol Venereol 2015 0.75
147 Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study. J Dermatolog Treat 2006 0.75
148 Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies. Immunopharmacol Immunotoxicol 2012 0.75
149 Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines. G Ital Dermatol Venereol 2015 0.75
150 Critical appraisal of the unmet needs in the treatment of chronic spontaneous urticaria with omalizumab: an Italian perspective. Curr Opin Allergy Clin Immunol 2017 0.75
151 Lipoatrophia semicircularis: a case report and review of the literature. G Ital Dermatol Venereol 2016 0.75
152 Uncombable hair syndrome, mental retardation, single palmar crease and arched palate in a patient with neurofibromatosis type I. Pediatr Dermatol 2007 0.75
153 Disseminated lupus vulgaris. Eur J Dermatol 2003 0.75